The Sarah Cannon Cancer Center — Nashville, Tennessee

The Sarah Cannon Cancer Center is a clinical research site located in Nashville, Tennessee, United States 37203.

Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.

The Sarah Cannon Cancer Center has participated in 16 clinical trials.

Therapeutic areas: Refractory Solid Tumors, Lymphoma, Hematological Malignancies.

Sponsors: Erimos Pharmaceuticals, Synta Pharmaceuticals Corp., Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Sarah Cannon Cancer Center?

The Sarah Cannon Cancer Center has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Sarah Cannon Cancer Center conducted?

The Sarah Cannon Cancer Center has 16 clinical trials on record. Their work covers Refractory Solid Tumors, Lymphoma, Hematological Malignancies.

Is The Sarah Cannon Cancer Center accredited by Crixeo Health?

Yes — The Sarah Cannon Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about The Sarah Cannon Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.